Adrianne L. Jenner
George St
Brisbane, QLD 4000, Australia
Brisbane, QLD 4000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
In silico clinical trials of BiTE expression by oncolytic viruses reveal the impact of patient heterogeneity on dosage protocol.
Journal: PLoS computational biology
Published: February 02, 2026
A mathematical model for inflammation and demyelination in multiple sclerosis.
Journal: Journal of the Royal Society, Interface
Published: July 31, 2025
Bayesian uncertainty quantification to identify population level vaccine hesitancy behaviours.
Journal: PloS one
Published: June 26, 2025
Therapeutic targeting of oligodendrocytes in an agent-based model of multiple sclerosis.
Journal: PLoS computational biology
Published: June 24, 2025
A hybrid discrete-continuum modelling approach for the interactions of the immune system with oncolytic viral infections.
Journal: Journal of theoretical biology
Published: April 18, 2025
Integrative spatial omics and artificial intelligence: transforming cancer research with omics data and AI.
Journal: Seminars in cancer biology
Published: March 14, 2025
Identifiability of phenotypic adaptation from low-cell-count experiments and a stochastic model.
Journal: PLoS computational biology
Published: January 20, 2025
Using virtual patient cohorts to uncover immune response differences in cancer and immunosuppressed COVID-19 patients.
Journal: PLoS computational biology
Published: September 15, 2024
Reducing phenotype-structured partial differential equations models of cancer evolution to systems of ordinary differential equations: a generalised moment dynamics approach.
Journal: Journal of mathematical biology
Published: September 03, 2024
Using virtual patient cohorts to uncover immune response differences in cancer and immunosuppressed COVID-19 patients.
Journal: bioRxiv : the preprint server for biology
Published: August 12, 2024
Mathematical modeling predicts pathways to successful implementation of combination TRAIL-producing oncolytic virus and PAC-1 to treat granulosa cell tumors of the ovary.
Journal: Cancer biology & therapy
Published: November 27, 2023
Last Updated: 09/26/2026